Millions of people remain at risk of developing long Covid, with a bewildering array of potentially debilitating symptoms
As vaccines blunt the threat of severe illness and death from Covid-19, millions of people remain at risk of developing an array of less serious but potentially debilitating long-term symptoms of the disease that scientists call long Covid.
Many of the most vulnerable are among younger unvaccinated people who are unprotected against the rapidly spreading Delta variant of the coronavirus, now responsible forLong Covid—a term referring to symptoms that linger for weeks or months beyond infection—affects between 10% and 30% of people who catch the virus, including those with mild or asymptomatic infections, according to experts.
as states relax restrictions and the highly transmissible Delta variant spreads. That increase won’t cause as many cases of serious illness or death as in previous waves, thanks to high vaccination uptake among the oldest and most vulnerable. But it could lead to
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Covid vaccines: Why a giant plastic bag shortage is slowing the rolloutA look at the critical vaccine components in short supply, as a new global marketplace is launched to tackle bottlenecks.
Leer más »
Covid Benefits: The Italian Billionaire Family Making Glass Vials For Vaccines Scores With U.S. IPOThe 72-year-old firm based in northern Italy debuted on the New York Stock Exchange in a rare public listing for an Italian company, adding $550 million to the Stevanato family’s coffers.
Leer más »
The Italian Billionaire Family Making Glass Vials For Covid Vaccines Scores With U.S. IPOThe 72-year-old firm based in northern Italy debuted on the New York Stock Exchange in a rare public listing for an Italian company, adding $550 million to the Stevanato family’s coffers.
Leer más »
U.S. Buys 200 Million Covid-19 Vaccines From Pfizer and BioNTech at About $24 a ShotThe U.S. is paying about $24 a dose, according to Pfizer, up from the $19.50 that the government paid in its earlier deals. The deal brings the total purchased from the U.S. to 1 billion doses.
Leer más »
LA man who mocked Covid-19 vaccines dies of virusStephen Harmon, who opposed getting vaccinated, has died after a month-long struggle with the virus.
Leer más »
The Next Target for mRNA Vaccines After Covid-19: The FluIn the race to develop shots against Covid-19, mRNA vaccines beat out many traditional approaches. Now, the technology is squaring up to an old viral nemesis: influenza.
Leer más »